SOURCE-LINKED STUDY SUMMARY
Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials.
Abstract summarizedQuality not appraised
- What was studied
- A meta-analysis compared abnormal heart rhythms in randomized trials of tirzepatide versus placebo for overweight or obesity.
- Who / model studied
- Ten trials included 6515 participants, with 4491 assigned tirzepatide. Follow-up durations are not stated in the abstract.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Pooled results suggested higher odds of abnormal heart rhythms overall. For atrial fibrillation and other atrial rhythms specifically, the estimates were too uncertain to establish a difference.
- Limitations & context
- Events were uncommon, and the authors advise cautious interpretation.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1161/jaha.125.044249